Last reviewed · How we verify
LUT014 Gel
At a glance
| Generic name | LUT014 Gel |
|---|---|
| Sponsor | Lutris Pharma Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC (PHASE2)
- LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |